Over the past 8 years we have identified several novel and potentially serious health consequences associated with crack cocaine. Our research has examined two general areas: 1) the effects of crack cocaine on lung inflammation, injury and physiology and 2) the impact of cocaine on immunity and host defense. This second line of investigation, the impact of cocaine on immunity and host defense, has become the primary focus for this competitive renewal. In this respect, we have demonstrated that alveolar macrophages recovered from the lungs of crack users exhibit a marked deficiency in their ability to upregulate inducible nitric oxide synthase, produce nitric oxide, and limit the growth of Staphylococcus aureus. When tested in a mouse model, cocaine adversely regulated T-helper cytokine (Thl/Th2) balance leading to over-expression of TGF-beta and IL-10, suppressed T cell function, and allowed the uncontrolled growth of implanted lung tumor cells. Novel experiments have identified sigma receptors as likely to be involved in these effects both in vitro and in vivo. We have also developed an important new model for studying the interaction between cocaine and HIV. Administration of cocaine to severe-combined immunodeficiency (SCID) mice reconstituted with human peripheral blood leukocytes (huPBL/SCID), and infected with HIV, results in dramatic increases in viral replication, down-regulation of CD4 counts and CD4/CD8 ratios, and changes in expression of HIV co-receptors. More recently, we have identified altered immune function in blood collected from crack-abusing subjects. Building on these findings, we propose 3 specific aims' 1) To define the mechanisms by which cocaine enhances HIV replication and infection in vivo in the huPBL/SCID and SCID-hu models. 2) To determine the pathway(s) by which cocaine suppresses immune responses in a murine model of anti-tumor immunity (effects on T cells, dendritic cells, cytokines) and delineate the role of the sigma-receptor signaling in this process. 3) To demonstrate the type and magnitude of cocaine-related alterations in HIV co-factors and immune function as they occur in a well-described cohort of crack cocaine users. Correlations will also be sought between a history of crack use and the development and progression of HIV-related diseases in an established database from the Multicenter AIDS Cohort Study (MACS). By the completion of these studies we will have relevant animal data and human clinical correlates linking inhaled cocaine abuse to the regulation of immune function and host defense, and the modulation of risk factors important to the pathogenesis and progression of HIV.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA008254-11
Application #
6848738
Study Section
AIDS and Related Research 8 (AARR)
Program Officer
Thadani, Pushpa
Project Start
1993-06-01
Project End
2007-01-31
Budget Start
2005-02-01
Budget End
2006-01-31
Support Year
11
Fiscal Year
2005
Total Cost
$485,362
Indirect Cost
Name
University of California Los Angeles
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Chao, Chun; Jacobson, Lisa P; Tashkin, Donald et al. (2009) Recreational amphetamine use and risk of HIV-related non-Hodgkin lymphoma. Cancer Causes Control 20:509-16
Chao, Chun; Jacobson, Lisa P; Jenkins, Frank J et al. (2009) Recreational drug use and risk of Kaposi's sarcoma in HIV- and HHV-8-coinfected homosexual men. AIDS Res Hum Retroviruses 25:149-56
Chao, Chun; Jacobson, Lisa P; Tashkin, Donald et al. (2008) Recreational drug use and T lymphocyte subpopulations in HIV-uninfected and HIV-infected men. Drug Alcohol Depend 94:165-71
Roth, Michael D; Whittaker, Katherine M; Choi, Ruth et al. (2005) Cocaine and sigma-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model. J Leukoc Biol 78:1198-203
Roth, Michael D; Whittaker, Katherine; Salehi, Ken et al. (2004) Mechanisms for impaired effector function in alveolar macrophages from marijuana and cocaine smokers. J Neuroimmunol 147:82-6
Gardner, Brian; Zhu, Li X; Roth, Michael D et al. (2004) Cocaine modulates cytokine and enhances tumor growth through sigma receptors. J Neuroimmunol 147:95-8
Zhu, Li X; Sharma, Sherven; Gardner, Brian et al. (2003) IL-10 mediates sigma 1 receptor-dependent suppression of antitumor immunity. J Immunol 170:3585-91
Shay, Angela Hanchi; Choi, Ruth; Whittaker, Katherine et al. (2003) Impairment of antimicrobial activity and nitric oxide production in alveolar macrophages from smokers of marijuana and cocaine. J Infect Dis 187:700-4
Baldwin, Gayle Cocita; Choi, Ruth; Roth, Michael D et al. (2002) Evidence of chronic damage to the pulmonary microcirculation in habitual users of alkaloidal (""crack"") cocaine. Chest 121:1231-8
Kleerup, Eric C; Koyal, Sankar N; Marques-Magallanes, Jose A et al. (2002) Chronic and acute effects of ""crack"" cocaine on diffusing capacity, membrane diffusion, and pulmonary capillary blood volume in the lung. Chest 122:629-38

Showing the most recent 10 out of 23 publications